comparemela.com
Home
Live Updates
Quantum Leap Healthcare Collaborative Announce Termination of the Cyproheptadine Treatment Arm for Critically Ill COVID-19 Patients in the I-SPY COVID Trial : comparemela.com
Quantum Leap Healthcare Collaborative Announce Termination of the Cyproheptadine Treatment Arm for Critically Ill COVID-19 Patients in the I-SPY COVID Trial
/PRNewswire/ -- Quantum Leap Healthcare Collaborative (QLHC), sponsor of the I-SPY COVID Trial, announced that the cyproheptadine arm of the study has been...
Related Keywords
United States ,
California ,
San Francisco ,
Sara Auld ,
John Kazianis ,
Laura Esserman ,
University Of California ,
Department Of Defense Do ,
Program Executive Office ,
Department Of Defense ,
Biomedical Advanced Research ,
World Health Organization ,
Data Monitoring Committee ,
Development Authority ,
International Partners ,
Trial Biomarker Working Group ,
Defense Consortium ,
Defense Threat Reduction Agency ,
Leap Healthcare Collaborative ,
Fady Youssef ,
Biomarker Working Group ,
Assistant Secretary ,
Joint Program Executive Office ,
Quantum Leap Healthcare Collaborative ,
Silicon Valley ,
Mass Destruction ,
Serial Studies ,
Predict Your ,
Biomarker Integration ,
Adaptive Learning ,
Quantum Leap Healthcare ,
Leap Healthcare ,
comparemela.com © 2020. All Rights Reserved.